ETS like-1 protein ELK1-induced lncRNA LINC01638 accelerates the progression of papillary thyroid cancer by regulating Axin2 through Wnt/β-catenin signaling pathway

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30.
   PubMed Web of Science ®Google Scholar
• Integrated genomic characterization of papillary thyroid carcinoma. Integrated Genomic Characterization of Papillary Thyroid Carcinoma. Cell. 2014;159(3): 676–690.
   PubMed Web of Science ®Google Scholar
• Jendrzejewski J, Thomas A, Liyanarachchi S, et al. PTCSC3 is involved in papillary thyroid carcinoma development by modulating S100A4 gene expression. J Clin Endocrinol Metab. 2015;100(10):E1370–1377.
   PubMed Web of Science ®Google Scholar
• Miccoli P, Bakkar S. Surgical management of papillary thyroid carcinoma: an overview. Updates Surg. 2017;69(2):145–150.
   PubMed Web of Science ®Google Scholar
• Xing M. Molecular pathogenesis and mechanisms of thyroid cancer. Nat Rev Cancer. 2013;13(3):184–199.
   PubMed Web of Science ®Google Scholar
• Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009;136(4):629–641.
   PubMed Web of Science ®Google Scholar
• Liu X, Chen H, Kong W, et al. Down-regulated long non-coding RNA-ATB in preeclampsia and its effect on suppressing migration, proliferation, and tube formation of trophoblast cells. Placenta. 2017;49:80–87.
   PubMed Web of Science ®Google Scholar
• Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017;77(15):3965–3981.
   PubMed Web of Science ®Google Scholar
• Sanchez Calle A, Kawamura Y, Yamamoto Y, et al. Emerging roles of long non-coding RNA in cancer. Cancer Sci. 2018;109(7):2093–2100.
   PubMed Web of Science ®Google Scholar
• Li CH, Chen Y. Targeting long non-coding RNAs in cancers: progress and prospects. Int J Biochem Cell Biol. 2013;45(8):1895–1910.
   PubMed Web of Science ®Google Scholar
• Teng H, Mao F, Liang J, et al. Transcriptomic signature associated with carcinogenesis and aggressiveness of papillary thyroid carcinoma. Theranostics. 2018;8(16):4345–4358.
   PubMed Web of Science ®Google Scholar
• Zhuo W, Hu D, Chen X, et al. LINC01638 silencing inhibits cancer cell proliferation in colorectal adenocarcinoma through interaction with RUNX2. Mol Med Rep. 2019;19(6):5275–5280.
   PubMed Web of Science ®Google Scholar
• Luo L, Tang H, Ling L, Li N, Jia X, Zhang Z, Wang X, Shi L, Yin J, Qiu N, Liu H, Song Y, Luo K, Li H, He Z, Zheng G, Xie X. LINC01638 lncRNA activates MTDH-Twist1 signaling by preventing SPOP-mediated c-Myc degradation in triple-negative breast cancer. Oncogene. 2018;37(47): 6166–6179.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Yuan S, Luan X, Han G, et al. LINC01638 lncRNA mediates the postoperative distant recurrence of bladder cancer by upregulating ROCK2. Oncol Lett. 2019;18(5):5392–5398.
   PubMed Web of Science ®Google Scholar
• Guo L, Fang L, Liu Y. SP1-regulated LINC01638 promotes proliferation and inhibits apoptosis in non-small cell lung cancer. Eur Rev Med Pharmacol Sci. 2019;23(20):8913–8920.
   PubMed Web of Science ®Google Scholar
• Lu H, Ye J, Zhang L, et al. Downregulation of LINC01638 lncRNA inhibits migration and invasion of pancreatic ductal adenocarcinoma cells by reducing TGFbeta signaling. Mol Med Rep. 2019;20(5):4533–4539.
   PubMed Web of Science ®Google Scholar
• Lan X, Zhang H, Wang Z, et al. Genome-wide analysis of long noncoding RNA expression profile in papillary thyroid carcinoma. Gene. 2015;569(1):109–117.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Wang H, Wu C, et al. Construction and investigation of lncRNA-associated ceRNA regulatory network in papillary thyroid cancer. Oncol Rep. 2018;39(3):1197–1206.
   PubMed Web of Science ®Google Scholar
• Renganathan A, Felley-Bosco E. Long noncoding RNAs in cancer and therapeutic potential. Adv Exp Med Biol. 2017;1008:199–222.
   PubMed Web of Science ®Google Scholar
• Lei H, Gao Y, Xu X. LncRNA TUG1 influences papillary thyroid cancer cell proliferation, migration and EMT formation through targeting miR-145. Acta Biochim Biophys Sin (Shanghai). 2017;49(7):588–597.
   PubMed Web of Science ®Google Scholar
• Zhang XF, Ye Y, Zhao SJ. LncRNA Gas5 acts as a ceRNA to regulate PTEN expression by sponging miR-222-3p in papillary thyroid carcinoma. Oncotarget. 2018;9(3):3519–3530.
   PubMedGoogle Scholar
• Liu Y, Zhang H, Wang H, et al. Long non-coding RNA DUXAP8 promotes the cell proliferation, migration, and invasion of papillary thyroid carcinoma via miR-223-3p mediated regulation of CXCR4. Bioengineered. 2021;12(1):496–506.
   PubMed Web of Science ®Google Scholar
• Liu R, Xing M. TERT promoter mutations in thyroid cancer. Endocr Relat Cancer. 2016;23(3):R143–155.
   PubMed Web of Science ®Google Scholar
• Liu D, Liu Z, Condouris S, et al. BRAF V600E maintains proliferation, transformation, and tumorigenicity of BRAF-mutant papillary thyroid cancer cells. J Clin Endocrinol Metab. 2007;92(6):2264–2271.
   PubMed Web of Science ®Google Scholar
• Bullock M, Lim G, Li C, et al. Thyroid transcription factor FOXE1 interacts with ETS factor ELK1 to co-regulate TERT. Oncotarget. 2016;7(52):85948–85962.
   PubMedGoogle Scholar
• Farrell AS, Sears RC. MYC degradation. Cold Spring Harb Perspect Med. 2014;4(3):3.
   Web of Science ®Google Scholar
• Beroukhim R, Mermel CH, Porter D, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010;463(7283):899–905.
   PubMed Web of Science ®Google Scholar
• Huang J, Lin H, Zhong M, et al. Role of Lin28A/let-7a/c-Myc pathway in growth and malignant behavior of papillary thyroid carcinoma. Med Sci Monit. 2018;24:8899–8909.
   PubMed Web of Science ®Google Scholar
• Wang Y, Huang H, Hu F, et al. CITED1 contributes to the progression of papillary thyroid carcinoma via the Wnt/beta-catenin signaling pathway. Onco Targets Ther. 2019;12:6769–6777.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Liu Y, Ma M, et al. Knockdown of TRIM44 inhibits the proliferation and invasion in papillary thyroid cancer cells through suppressing the Wnt/beta-catenin signaling pathway. Biomed Pharmacother. 2017;96:98–103.
   PubMed Web of Science ®Google Scholar
• Zhang X, Li M, Zuo K, Li D, Ye M, Ding L, Cai H, Fu D, Fan Y, Lv Z. Upregulated miR-155 in papillary thyroid carcinoma promotes tumor growth by targeting APC and activating Wnt/beta-catenin signaling. J Clin Endocrinol Metab. 2013;98(8): E1305–1313.
   PubMed Web of Science ®Google Scholar
• Yu S, Cao S, Hong S, et al. miR-3619-3p promotes papillary thyroid carcinoma progression via Wnt/beta-catenin pathway. Ann Transl Med. 2019;7(22):643.
   PubMed Web of Science ®Google Scholar
• Wang X, Lu X, Geng Z, et al. LncRNA PTCSC3/miR-574-5p governs cell proliferation and migration of papillary thyroid carcinoma via wnt/beta-catenin signaling. J Cell Biochem. 2017;118(12):4745–4752.
   PubMed Web of Science ®Google Scholar
• Ding S, Qu W, Jiao Y, Zhang J, Zhang C, Dang S. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/beta-catenin signaling pathway. Cancer Biomarkers. 2018;22(2): 217–226.
   PubMed Web of Science ®Google Scholar
• Sheng K, Lu J, Zhao H. ELK1-induced upregulation of lncRNA HOXA10-AS promotes lung adenocarcinoma progression by increasing Wnt/beta-catenin signaling. Biochem Biophys Res Commun. 2018;501(3):612–618.
   PubMed Web of Science ®Google Scholar
• Ramos-Garcia P, Gil-Montoya JA, Scully C, et al. An update on the implications of cyclin D1 in oral carcinogenesis. Oral Dis. 2017;23(7):897–912.
   PubMed Web of Science ®Google Scholar
• Sanjari M, Kordestani Z, Safavi M, et al. Enhanced expression of Cyclin D1 and C-myc, a prognostic factor and possible mechanism for recurrence of papillary thyroid carcinoma. Sci Rep. 2020;10(1):5100.
   PubMed Web of Science ®Google Scholar
• Jho EH, Zhang T, Domon C, et al. Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol. 2002;22(4):1172–1183.
   PubMed Web of Science ®Google Scholar